This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-010-1473-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Occult Nesidioblastosis Detected by 111In-Pentetreotide Single-Photon Emission Computed Tomography.
Acta Med Okayama
October 2024
Department of Gastroenteorlogical Surgery, Kochi Health Sciences Center.
Nesidioblastosis, also known as persistent hyperinsulinemic hypoglycemia, is usually observed in children and infants, although more recently adult-onset nesidioblastosis has also been described. We present a case of nesidioblastosis in a 78-year-old man that was detected by 111In-pentetreotide single photon emission computed tomography (SPECT/CT). The patient was transferred to our hospital's emergency department in a hypoglycemic coma.
View Article and Find Full Text PDFFSH-producing pituitary neuroendocrine tumor as a cause of ovarian hyperstimulation syndrome.
Endocrinol Diabetes Metab Case Rep
January 2024
Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Summary: Functioning gonadotroph tumors are rare neoplasms that can cause ovarian hyperstimulation syndrome (OHSS) in women of reproductive age. Here, we present a case of a follicle-stimulating hormone (FSH)-producing pituitary neuroendocrine tumor (PitNET) with irregular menstrual cycles and OHSS in a Japanese woman. A 34-year-old woman with bilateral multi-cystic ovarian mass was referred to our hospital for ovarian surgery.
View Article and Find Full Text PDFCombined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
Jpn J Radiol
May 2024
Department of Radiology and Radiation Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Article Synopsis
- Somatostatin receptor scintigraphy (SRS) with In-DTPA-DPhe-octreotide is key for managing neuroendocrine neoplasms, but precise quantification is lacking.* -
- This study analyzed 21 patients, calculating standardized uptake values (SUVs) for liver, kidney, and spleen to improve the assessment of neuroendocrine tumors (NETs) through a combination of visual scoring and quantitative analysis.* -
- Results showed significant correlations between higher SUVs and visual scores, confirming the utility of combined visual and quantitative methods for better lesion characterization and staging of NETs.*
Primary Presacral Neuroendocrine Tumor Presenting as Multiple Liver Metastasis: A Case Report.
Am J Case Rep
July 2023
Department of Gastroenterology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Hyogo, Japan.
BACKGROUND Various neoplasms, including neuroendocrine neoplasms (NENs), can arise from the presacral space. Most presacral lesions are detected due to symptoms arising from tumor growth. However, diagnosing small, asymptomatic presacral tumors is challenging because of their unique location.
View Article and Find Full Text PDFImpact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic Review.
Clin Nucl Med
June 2023
From the Unità di Medicina Nucleare, GSTeP Radiofarmacia, TracerGLab, Dipartimento di Radiologia, Radioterapia ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Purpose: The interactions between the administration of cold somatostatin analogs (cSAs) and their radiolabeled counterpart remain unclear, and discontinuation before imaging is still advised as a precaution. The aim of this systematic review is to evaluate the consequences of cSA administration on tumoral and surrounding healthy organs' uptake at somatostatin receptor (SSTR) imaging with SPECT or PET.
Methods: After registration of the study on Prospero (CRD42022360260), an electronic search of PubMed and Scopus databases was performed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!